Clindamycin Hydrochloride
Product Images NDC 10544-154

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Clindamycin Hydrochloride (NDC 10544-154). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blenheim Pharmacal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

300mg 30ct (Label Clindamycin HCl Caps 300mg Bpi(10544 154 30) Watson(0591 3120 01) Rev1)

Label for Clindamycin Hydrochloride Capsules, USP 300 mg, containing 30 capsules. The label includes NDC 10544-154-30, manufacturer code MFG 0591-3120-01, dosage storage instructions (20°-25°C), and notes it is prescription only. Distributed by Watson Pharma, repackaged by Blenheim Pharmacal, Inc. with lot and expiration placeholders. The right side repeats product and lot information in smaller print.*

FDA Label Image

Structure (Clindamycin HCl Capsule 1)

Chemical structure of clindamycin hydrochloride. The diagram shows the molecular arrangement of clindamycin with a hydrochloride salt indicated.*

FDA Label Image

Table 1 (Clindamycin HCl Capsule 2)

Data table titled 'Susceptibility Interpretive Criteria for Clindamycin' showing minimal inhibitory concentrations (MIC in mcg/mL) and disk diffusion zone diameters (in mm) for various pathogens including Staphylococcus spp., Streptococcus pneumoniae and other Streptococcus spp., and Anaerobic Bacteria. It specifies breakpoints for susceptibility (S), intermediate (I), and resistance (R) categories.*

FDA Label Image

Table 2 (Clindamycin HCl Capsule 3)

A data table titled 'Acceptable Quality Control Ranges for Clindamycin to be Used in Validation of Susceptibility Test Results.' It lists QC strains, minimum inhibitory concentration ranges (mcg/mL), and disk diffusion ranges (zone diameters in mm) for aerobic pathogens and anaerobes, including Staphylococcus aureus, Streptococcus pneumoniae, Bacteroides fragilis, Bacteroides thetaiotaomicron, and Eubacterium lentum. NA denotes not applicable.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.